Cita APA

Suraev, A., Grunstein, R. R., Marshall, N. S., D'Rozario, A. L., Gordon, C. J., Bartlett, D. J., . . . Hoyos, C. M. (2020). Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): Protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. BMJ Open.

Chicago Style Citation

Suraev, Anastasia, et al. "Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for Chronic Insomnia Disorder (‘CANSLEEP’ Trial): Protocol for a Randomised, Placebo-controlled, Double-blinded, Proof-of-concept Trial." BMJ Open 2020.

Cita MLA

Suraev, Anastasia, et al. "Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for Chronic Insomnia Disorder (‘CANSLEEP’ Trial): Protocol for a Randomised, Placebo-controlled, Double-blinded, Proof-of-concept Trial." BMJ Open 2020.